Abbott Sues Chinese Rival Over Glucose Monitor UK Patent
Abbott has accused a Chinese rival of infringing two patents protecting tech that continuously monitors glucose levels in diabetes patients — the second attempt by the American company to block Sinocare...To view the full article, register now.
Already a subscriber? Click here to view full article